0000000001311039
AUTHOR
K. Provost
Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
Abstract Introduction VTE‐BLEED is a validated score for identification of patients at increased risk of major bleeding during extended anticoagulation for venous thromboembolism (VTE). It is unknown whether VTE‐BLEED high‐risk patients also have an increased risk for recurrent VTE, which would limit the potential usefulness of the score. Methods This was a post hoc analysis of the randomized, double‐blind, placebo‐controlled PADIS‐PE trial that randomized patients with a first unprovoked pulmonary embolism (PE) initially treated during 6 months to receive an additional 18‐month of warfarin vs. placebo. The primary outcome of this analysis was recurrent VTE during 2‐year follow‐up after ant…
CCDC 145000: Experimental Crystal Structure Determination
Related Article: P.J.van Koningsbruggen, Y.Garcia, O.Kahn, L.Fournes, H.Kooijman, A.L.Spek, J.G.Haasnoot, J.Moscovici, K.Provost, A.Michalowicz, F.Renz, P.Gutlich|2000|Inorg.Chem.|39|1891|doi:10.1021/ic991118n
CCDC 145001: Experimental Crystal Structure Determination
Related Article: P.J.van Koningsbruggen, Y.Garcia, O.Kahn, L.Fournes, H.Kooijman, A.L.Spek, J.G.Haasnoot, J.Moscovici, K.Provost, A.Michalowicz, F.Renz, P.Gutlich|2000|Inorg.Chem.|39|1891|doi:10.1021/ic991118n